Profile data is unavailable for this security.
About the company
Aurisco Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of specialty active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The Company's main products are respiratory, cardiovascular, anti-infective and nervous system drugs, including flumethasone, fluticasone propionate, eplerenone, tenofovir, pregabalin and other APIs and intermediates. The Company distributes its products in domestic market and to overseas markets.
- Revenue in CNY (TTM)1.30bn
- Net income in CNY325.73m
- Incorporated1998
- Employees1.52k
- LocationAurisco Pharmaceutical Co LtdNo. 1 Longxing RoadBadu Industrial Park, Tiantai CountyTAIZHOU 317200ChinaCHN
- Phone+86 57 683170900
- Fax+86 57 683170900
- Websitehttps://www.aurisco.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liaoning Chengda Biotechnology Co Ltd | 1.76bn | 420.34m | 9.93bn | 1.73k | 23.53 | 1.02 | -- | 5.64 | 1.01 | 1.01 | 4.26 | 23.41 | 0.1743 | 0.7061 | 1.61 | 1,016,911.00 | 4.16 | 10.63 | 4.27 | 11.01 | 81.48 | 85.74 | 23.87 | 39.56 | 20.80 | -- | 0.002 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
Heilongjiang ZBD Pharmaceutical Co Ltd | 2.73bn | 511.96m | 10.40bn | 2.55k | 20.27 | 1.32 | -- | 3.81 | 0.5447 | 0.5447 | 2.90 | 8.35 | 0.2186 | 1.58 | 0.8134 | 1,071,832.00 | 4.06 | 3.48 | 5.61 | 4.78 | 46.09 | 38.93 | 18.56 | 10.08 | 2.35 | -- | 0.2862 | 27.18 | -25.50 | 2.45 | 155.00 | 0.4417 | -25.68 | 4.05 |
Tibet Rhodiola Pharmaceutical Holding Co | 2.93bn | 810.63m | 10.58bn | 601.00 | 11.70 | 2.22 | -- | 3.61 | 2.81 | 2.81 | 9.65 | 14.76 | 0.6016 | 1.81 | 6.68 | 4,877,892.00 | 16.83 | 12.44 | 23.18 | 15.71 | 93.68 | 90.51 | 27.97 | 20.43 | 2.79 | 7.96 | 0.1716 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
Zhejiang Medicine Co., Ltd. | 8.04bn | 425.74m | 10.64bn | 6.23k | 24.75 | 1.09 | -- | 1.32 | 0.447 | 0.447 | 8.41 | 10.13 | 0.6329 | 2.91 | 5.57 | 1,290,409.00 | 2.14 | 4.32 | 2.75 | 5.68 | 31.16 | 36.57 | 3.39 | 6.28 | 1.62 | 5.95 | 0.0819 | 58.72 | -3.96 | 2.59 | -20.37 | 3.34 | 12.65 | 0.00 |
Aurisco Pharmaceutical Co Ltd | 1.30bn | 325.73m | 10.87bn | 1.52k | 33.34 | 5.23 | -- | 8.39 | 0.803 | 0.803 | 3.18 | 5.12 | 0.5404 | 1.17 | 4.99 | 852,082.90 | 13.57 | 12.40 | 16.46 | 14.33 | 56.90 | 51.26 | 25.12 | 23.05 | 1.72 | -- | 0.116 | 25.15 | 25.24 | 17.02 | 37.23 | 16.16 | 26.54 | -- |
Jiangxi Tianxin Pharmaceutical Co Ltd | 1.80bn | 514.80m | 11.20bn | 2.47k | 21.75 | 2.57 | -- | 6.23 | 1.18 | 1.18 | 4.11 | 9.95 | 0.36 | 2.68 | 6.66 | 727,792.60 | 10.31 | -- | 11.11 | -- | 39.78 | -- | 28.63 | -- | 5.51 | -- | 0.0551 | -- | -18.34 | -- | -23.51 | -- | -- | -- |
Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.43bn | 523.43m | 11.54bn | 8.41k | 22.22 | 1.62 | -- | 1.80 | 0.202 | 0.202 | 2.49 | 2.78 | 0.5568 | 2.39 | 4.60 | 764,058.90 | 5.02 | 6.77 | 7.25 | 10.50 | 54.36 | 63.24 | 9.02 | 11.10 | 1.53 | 40.71 | 0.1459 | 42.32 | 12.20 | -0.8267 | 65.20 | -6.21 | -11.64 | 5.92 |
Mayinglong Pharmaceutical Group Co Ltd | 3.26bn | 453.31m | 11.55bn | 2.88k | 25.48 | 2.95 | -- | 3.54 | 1.05 | 1.05 | 7.56 | 9.08 | 0.6482 | 5.87 | 11.13 | 1,130,851.00 | 9.26 | 10.82 | 11.03 | 13.47 | 42.87 | 41.18 | 14.29 | 14.08 | 5.18 | -- | 0.0729 | 33.04 | -11.20 | 7.38 | -7.46 | 20.26 | 58.33 | 21.67 |
Data as of Jul 05 2024. Currency figures normalised to Aurisco Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.05%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
China Asset Management Co., Ltd.as of 31 Dec 2023 | 5.76m | 1.46% |
SWS MU Fund Management Co., Ltd.as of 31 Dec 2023 | 1.55m | 0.39% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.29m | 0.33% |
Broad Fund Management Co. Ltd.as of 31 Dec 2023 | 941.30k | 0.24% |
Chang Xin Asset Management Co., Ltd.as of 31 Dec 2023 | 787.50k | 0.20% |
Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 731.50k | 0.19% |
Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 500.00k | 0.13% |
VanEck Australia Pty Ltd.as of 07 Jun 2024 | 183.40k | 0.05% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 180.90k | 0.05% |
Fuanda Fund Management Co., Ltd.as of 31 Dec 2023 | 124.40k | 0.03% |
More ▼
Data from 31 Dec 2023 - 03 Jul 2024Source: FactSet Research Systems Inc.